I don't think so...market cap is already at $148M (its not $130M as shown in yahoo finance). July 30th is just panel recommendation, and stock is already up from mid 3s due to July 30th event.
I agree once FDA approval does come, it may go up to $7-8. But that would be Q4FY14...who knows with FDA.
July 30th is NOT FDA approval. Plus FDA does not need to follow the recommendation either. Look it up.